Objective. To rank outcomes identified as important to patients with psoriatic arthritis (PsA) and examine their representation in existing composite measures. Methods. Seven nominal group technique (NGT) meetings took place at 4 hospital sites. Two sorting rounds were conducted to generate a shortlist of outcomes followed by a group discussion and final ranking. In the final ranking round, patients were given 15 points each and asked to rank their top 5 outcomes from the shortlist. The totals were summed across the 7 NGT groups and were presented as a percentage of the maximum possible priority score. Results. Thirty-one patients took part: 16 men and 15 women; the mean age was 54 years (range 24–77; SD 12.2), the mean diseas...
© 2017, The Author(s). Background: Psoriatic arthritis (PsA) is a variable and complex inflammatory ...
Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical phenotype...
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures...
Objective. To rank outcomes identified as important to patients with psoriatic arthritis (PsA) and e...
© Copyright 2017 The Journal of Rheumatology. All rights reserved. Objective. To rank outcomes ident...
Background: An updated psoriatic arthritis (PsA) core outcome set (COS) for randomized controlled tr...
BACKGROUND: An updated psoriatic arthritis (PsA) core outcome set (COS) for randomized controlled tr...
Objective A meeting was convened by the Group for Research and Assessment of Psoriasis and Psoria...
OBJECTIVE: A meeting was convened by the Group for Research and Assessment of Psoriasis and Psoriati...
Background Many composite disease activity measures and targets have been developed for psoriatic ar...
Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA) c...
Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA) c...
Introduction The objective was to develop a questionnaire that can be used to calculate a score refl...
Background: Qualitative studies are lacking in Psoriatic Arthritis (PsA), to increase the knowledge ...
OBJECTIVE: Improving the assessment of psoriatic arthritis (PsA) is a key purpose of the Group for R...
© 2017, The Author(s). Background: Psoriatic arthritis (PsA) is a variable and complex inflammatory ...
Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical phenotype...
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures...
Objective. To rank outcomes identified as important to patients with psoriatic arthritis (PsA) and e...
© Copyright 2017 The Journal of Rheumatology. All rights reserved. Objective. To rank outcomes ident...
Background: An updated psoriatic arthritis (PsA) core outcome set (COS) for randomized controlled tr...
BACKGROUND: An updated psoriatic arthritis (PsA) core outcome set (COS) for randomized controlled tr...
Objective A meeting was convened by the Group for Research and Assessment of Psoriasis and Psoria...
OBJECTIVE: A meeting was convened by the Group for Research and Assessment of Psoriasis and Psoriati...
Background Many composite disease activity measures and targets have been developed for psoriatic ar...
Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA) c...
Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA) c...
Introduction The objective was to develop a questionnaire that can be used to calculate a score refl...
Background: Qualitative studies are lacking in Psoriatic Arthritis (PsA), to increase the knowledge ...
OBJECTIVE: Improving the assessment of psoriatic arthritis (PsA) is a key purpose of the Group for R...
© 2017, The Author(s). Background: Psoriatic arthritis (PsA) is a variable and complex inflammatory ...
Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical phenotype...
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures...